Soluble anti-müllerian hormone receptor type 2 (SAMHR2): A new biomarker for diagnosis of fertility disorders

Josef van Helden; lascols olivier; Osman Evliyaoğlu; Ralf Weiskirchen

doi:10.1016/j.cca.2019.03.750

Related publications

Article2019

Investigation of soluble anti-Müllerian hormone receptor type 2 as a biomarker for diagnosis of female fertility disorders

Lena Sophie Olivier, Osman Evliyaoğlu, Ralf Weiskirchen, Josef van Helden

Article2013

Soluble urokinase–type plasminogen activator receptor as a prognostic biomarker in critically ill patients

Katia Donadello, Sabino Scolletta, Fabio Silvio Taccone, Cecilia Covajes, Cristina Santonocito, Diego Orbegozo Cortés, Daiva Gražulytė, Leonardo Gottin, Jean Louis Vincent

Article2015

Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assay

Josef van Helden, Ralf Weiskirchen

Article2020

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) As a Biomarker of Renal Outcomes in AL Amyloidosis

Efstathios Kastritis, Ioannis Papassotiriou, Foteini Theodorakakou, Alexandra Margeli, Anastasia Barzteliotou, Eleni Tsiligkeridou, Amalia Andreatou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Ioanna Dialoupi, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Evangelos Terpos, Meletios A Dimopoulos

Article2017

Non-equivalence of anti-Müllerian hormone automated assays—clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing

Stamatina Iliodromiti, Barbara Salje, Didier Dewailly, Craig Fairburn, Rénato Fanchin, Richard Fleming, Raymond Li, Krzysztof Łukaszuk, Ernest Hung Yu Ng, Pascal Pigny, Teddy Tadros, Joseph van Helden, Ralf Weiskirchen, Scott M. Nelson